Name | peroxiredoxin 2 |
Description | This gene encodes a member of the peroxiredoxin family of antioxidant enzymes, which reduce hydrogen peroxide and alkyl hydroperoxides. The encoded protein plays an antioxidant protective role in cells, and it may contribute to the antiviral activity of CD8(+) T-cells. The crystal structure of this protein has been resolved to 2.7 angstroms. This protein prevents hemolytic anemia from oxidative stress by stabilizing hemoglobin, thus making this gene a therapeutic target for patients with hemolytic anemia. This protein may have a proliferative effect and play a role in cancer development or progression. Related pseudogenes have been identified on chromosomes 5, 6, 10 and 13. [provided by RefSeq, Mar 2013] |
Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nPeroxiredoxin‐2 (PRDX2) is a highly abundant, thiol‐dependent peroxidase that rapidly reduces hydrogen peroxide and organic hydroperoxides, thereby protecting cells from oxidative damage. Its exceptional kinetic reactivity, documented in erythrocytes and other cell types, enables efficient peroxide scavenging while its oligomeric organization (dimer/decamer equilibrium) is crucial for its rapid peroxidase activity. PRDX2 also participates in reversible post‐translational modifications such as glutathionylation—which can be reversed by glutaredoxin—and its sensitivity to hyperoxidation is regulated by specific molecular determinants. These characteristics collectively underscore its fundamental role in antioxidant defense and maintenance of redox homeostasis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "9"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its peroxidase function, PRDX2 plays an important role in redox signaling and cell‐regulatory processes. Under conditions of oxidative stress, its catalytic cysteine residues can become hyperoxidized or modified through S‐nitrosylation and acetylation—thereby altering its activity and participation in signal transduction pathways. For example, modified extracellular or nuclear forms of PRDX2 help modulate inflammatory responses (by stimulating cytokine release) or protect vulnerable signaling receptors (such as VEGFR2) and DNA repair systems in cancer cells. Moreover, in certain myeloid and glioma cells, proper maintenance of PRDX2 activity is implicated in cell cycle regulation and survival, while its targeted inhibition (by agents such as Celastrol) can trigger redox‐dependent apoptosis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "10", "end_ref": "20"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nClinically, alterations in PRDX2 expression and regulation have been linked to a broad spectrum of human diseases. In neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease—as well as in Down syndrome—the dysregulated levels or post‐translational modifications of PRDX2 appear to contribute to neuronal vulnerability. In inflammatory conditions (e.g. psoriasis) and a variety of cancers (including gastric, colorectal, breast, and acute myeloid leukemia), aberrant PRDX2 expression correlates with tumor progression, metastasis, and therapy resistance. In erythrocytes, PRDX2 not only protects hemoglobin and membrane proteins from oxidative denaturation but also plays a structural role through interactions with Band 3, while in placental trophoblasts its loss is associated with increased apoptosis linked to recurrent miscarriage. Intriguingly, even pathogens such as Plasmodium falciparum exploit host PRDX2 to bolster their own antioxidant defenses. These diverse functions highlight PRDX2 as a critical metabolic adaptor and a promising target for therapeutic intervention."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "21", "end_ref": "38"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "S H Kim, M Fountoulakis, N Cairns, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer's disease and Down syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neural Transm Suppl (2001)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/978-3-7091-6262-0_18"}], "href": "https://doi.org/10.1007/978-3-7091-6262-0_18"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11771746"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11771746"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Thierry Rabilloud, Manfred Heller, Francoise Gasnier, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Proteomics analysis of cellular response to oxidative stress. Evidence for in vivo overoxidation of peroxiredoxins at their active site."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M106585200"}], "href": "https://doi.org/10.1074/jbc.M106585200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11904290"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11904290"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Felicia M Low, Mark B Hampton, Alexander V Peskin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Peroxiredoxin 2 functions as a noncatalytic scavenger of low-level hydrogen peroxide in the erythrocyte."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2006-09-048728"}], "href": "https://doi.org/10.1182/blood-2006-09-048728"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17105810"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17105810"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Alexander V Peskin, Felicia M Low, Louise N Paton, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The high reactivity of peroxiredoxin 2 with H(2)O(2) is not reflected in its reaction with other oxidants and thiol reagents."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M700339200"}], "href": "https://doi.org/10.1074/jbc.M700339200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17329258"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17329258"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Weonsup Lee, Kyoung-Soo Choi, Jonah Riddell, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human peroxiredoxin 1 and 2 are not duplicate proteins: the unique presence of CYS83 in Prx1 underscores the structural and functional differences between Prx1 and Prx2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M610330200"}], "href": "https://doi.org/10.1074/jbc.M610330200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17519234"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17519234"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Bruno Manta, Martín Hugo, Cecilia Ortiz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The peroxidase and peroxynitrite reductase activity of human erythrocyte peroxiredoxin 2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arch Biochem Biophys (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.abb.2008.11.017"}], "href": "https://doi.org/10.1016/j.abb.2008.11.017"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19061854"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19061854"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Alexander V Peskin, Andrew G Cox, Péter Nagy, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Removal of amino acid, peptide and protein hydroperoxides by reaction with peroxiredoxins 2 and 3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem J (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BJ20101156"}], "href": "https://doi.org/10.1042/BJ20101156"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20840079"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20840079"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Alexander V Peskin, Paul E Pace, Jessica B Behring, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Glutathionylation of the Active Site Cysteines of Peroxiredoxin 2 and Recycling by Glutaredoxin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M115.692798"}], "href": "https://doi.org/10.1074/jbc.M115.692798"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26601956"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26601956"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Jesalyn A Bolduc, Kimberly J Nelson, Alexina C Haynes, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Novel hyperoxidation resistance motifs in 2-Cys peroxiredoxins."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.RA117.001690"}], "href": "https://doi.org/10.1074/jbc.RA117.001690"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29884768"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29884768"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Timothy J Phalen, Kelly Weirather, Paula B Deming, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Oxidation state governs structural transitions in peroxiredoxin II that correlate with cell cycle arrest and recovery."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1083/jcb.200606005"}], "href": "https://doi.org/10.1083/jcb.200606005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17145963"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17145963"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Jianguo Fang, Tomohiro Nakamura, Dong-Hyung Cho, et al. "}, {"type": "b", "children": [{"type": "t", "text": "S-nitrosylation of peroxiredoxin 2 promotes oxidative stress-induced neuronal cell death in Parkinson's disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0705904104"}], "href": "https://doi.org/10.1073/pnas.0705904104"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18003920"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18003920"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Thomas J Jönsson, Allen W Tsang, W Todd Lowther, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of intact protein thiosulfinate intermediate in the reduction of cysteine sulfinic acid in peroxiredoxin by human sulfiredoxin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.C800124200"}], "href": "https://doi.org/10.1074/jbc.C800124200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18593714"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18593714"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "R B Parmigiani, W S Xu, G Venta-Perez, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0803749105"}], "href": "https://doi.org/10.1073/pnas.0803749105"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18606987"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18606987"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Pameeka S Smith-Pearson, Mitra Kooshki, Douglas R Spitz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Decreasing peroxiredoxin II expression decreases glutathione, alters cell cycle distribution, and sensitizes glioma cells to ionizing radiation and H(2)O(2)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Free Radic Biol Med (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.freeradbiomed.2008.07.015"}], "href": "https://doi.org/10.1016/j.freeradbiomed.2008.07.015"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18718523"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18718523"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Kyung Wha Lee, Doo Jae Lee, Joo Young Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Peroxiredoxin II restrains DNA damage-induced death in cancer cells by positively regulating JNK-dependent DNA repair."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M110.179416"}], "href": "https://doi.org/10.1074/jbc.M110.179416"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21148313"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21148313"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Dong Hoon Kang, Doo Jae Lee, Kyung Wha Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Peroxiredoxin II is an essential antioxidant enzyme that prevents the oxidative inactivation of VEGF receptor-2 in vascular endothelial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molcel.2011.08.040"}], "href": "https://doi.org/10.1016/j.molcel.2011.08.040"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22099303"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22099303"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Sonia Salzano, Paola Checconi, Eva-Maria Hanschmann, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Linkage of inflammation and oxidative stress via release of glutathionylated peroxiredoxin-2, which acts as a danger signal."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1401712111"}], "href": "https://doi.org/10.1073/pnas.1401712111"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25097261"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25097261"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Meidan Ying, Xuejing Shao, Hui Jing, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ubiquitin-dependent degradation of CDK2 drives the therapeutic differentiation of AML by targeting PRDX2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2017-10-813139"}], "href": "https://doi.org/10.1182/blood-2017-10-813139"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29720484"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29720484"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Sen Wang, Zheng Chen, Shoumin Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PRDX2 protects against oxidative stress induced by H. pylori and promotes resistance to cisplatin in gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Redox Biol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.redox.2019.101319"}], "href": "https://doi.org/10.1016/j.redox.2019.101319"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31536951"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31536951"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Xi Chen, Ying Zhao, Wu Luo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Celastrol induces ROS-mediated apoptosis via directly targeting peroxiredoxin-2 in gastric cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Theranostics (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7150/thno.46728"}], "href": "https://doi.org/10.7150/thno.46728"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32929349"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32929349"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Kurt Krapfenbauer, Ephrem Engidawork, Nigel Cairns, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain Res (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s0006-8993(02)04243-9"}], "href": "https://doi.org/10.1016/s0006-8993(02"}, {"type": "t", "text": "04243-9) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12650976"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12650976"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "M F Sánchez-Font, J Sebastià, C Sanfeliu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Peroxiredoxin 2 (PRDX2), an antioxidant enzyme, is under-expressed in Down syndrome fetal brains."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Mol Life Sci (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00018-003-3048-1"}], "href": "https://doi.org/10.1007/s00018-003-3048-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12943237"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12943237"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Ji Won Park, John J Mieyal, Sue Goo Rhee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Deglutathionylation of 2-Cys peroxiredoxin is specifically catalyzed by sulfiredoxin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M109.021394"}], "href": "https://doi.org/10.1074/jbc.M109.021394"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19561357"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19561357"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Caroline Desmetz, Caroline Bascoul-Mollevi, Philippe Rochaix, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-08-3307"}], "href": "https://doi.org/10.1158/1078-0432.CCR-08-3307"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19584157"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19584157"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Sasa Koncarevic, Petra Rohrbach, Marcel Deponte, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The malarial parasite Plasmodium falciparum imports the human protein peroxiredoxin 2 for peroxide detoxification."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0905387106"}], "href": "https://doi.org/10.1073/pnas.0905387106"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19666612"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19666612"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Petra Besgen, Paul Trommler, Sigrid Vollmer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ezrin, maspin, peroxiredoxin 2, and heat shock protein 27: potential targets of a streptococcal-induced autoimmune response in psoriasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.0903520"}], "href": "https://doi.org/10.4049/jimmunol.0903520"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20363977"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20363977"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Shuchi Agrawal-Singh, Fabienne Isken, Konstantin Agelopoulos, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genome-wide analysis of histone H3 acetylation patterns in AML identifies PRDX2 as an epigenetically silenced tumor suppressor gene."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2011-06-358705"}], "href": "https://doi.org/10.1182/blood-2011-06-358705"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22207736"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22207736"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "V Stresing, E Baltziskueta, N Rubio, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Peroxiredoxin 2 specifically regulates the oxidative and metabolic stress response of human metastatic breast cancer cells in lungs."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2012.93"}], "href": "https://doi.org/10.1038/onc.2012.93"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22430214"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22430214"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Reagan M Jarvis, Stephanie M Hughes, Elizabeth C Ledgerwood "}, {"type": "b", "children": [{"type": "t", "text": "Peroxiredoxin 1 functions as a signal peroxidase to receive, transduce, and transmit peroxide signals in mammalian cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Free Radic Biol Med (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.freeradbiomed.2012.08.001"}], "href": "https://doi.org/10.1016/j.freeradbiomed.2012.08.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22902630"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22902630"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Ying-Hao Han, Sun-Uk Kim, Tae-Ho Kwon, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Peroxiredoxin II is essential for preventing hemolytic anemia from oxidative stress through maintaining hemoglobin stability."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2012.08.113"}], "href": "https://doi.org/10.1016/j.bbrc.2012.08.113"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22960070"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22960070"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Alessandro Matte, Mariarita Bertoldi, Narla Mohandas, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Membrane association of peroxiredoxin-2 in red cells is mediated by the N-terminal cytoplasmic domain of band 3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Free Radic Biol Med (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.freeradbiomed.2012.10.543"}], "href": "https://doi.org/10.1016/j.freeradbiomed.2012.10.543"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23123411"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23123411"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Paul E Pace, Alexander V Peskin, Min-Hi Han, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hyperoxidized peroxiredoxin 2 interacts with the protein disulfide- isomerase ERp46."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem J (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BJ20130030"}], "href": "https://doi.org/10.1042/BJ20130030"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23713588"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23713588"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Weidong Lu, Zhongxue Fu, Hao Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Peroxiredoxin 2 is upregulated in colorectal cancer and contributes to colorectal cancer cells' survival by protecting cells from oxidative stress."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biochem (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11010-013-1891-4"}], "href": "https://doi.org/10.1007/s11010-013-1891-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24234423"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24234423"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Victoria M Harper, Joo Yeun Oh, Ryan Stapley, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Peroxiredoxin-2 recycling is inhibited during erythrocyte storage."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Antioxid Redox Signal (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/ars.2014.5950"}], "href": "https://doi.org/10.1089/ars.2014.5950"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25264713"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25264713"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "John A Collins, Scott T Wood, Kimberly J Nelson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Oxidative Stress Promotes Peroxiredoxin Hyperoxidation and Attenuates Pro-survival Signaling in Aging Chondrocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M115.693523"}], "href": "https://doi.org/10.1074/jbc.M115.693523"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26797130"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26797130"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Fan Wu, Fuju Tian, Weihong Zeng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Role of peroxiredoxin2 downregulation in recurrent miscarriage through regulation of trophoblast proliferation and apoptosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cddis.2017.301"}], "href": "https://doi.org/10.1038/cddis.2017.301"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28661480"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28661480"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Zhenbing Lv, Jinlai Wei, Wenxian You, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Transl Med (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12967-017-1357-7"}], "href": "https://doi.org/10.1186/s12967-017-1357-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29258530"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29258530"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Yu Zhang, Jiajia Jiang, Jiayin Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CircDIDO1 inhibits gastric cancer progression by encoding a novel DIDO1-529aa protein and regulating PRDX2 protein stability."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12943-021-01390-y"}], "href": "https://doi.org/10.1186/s12943-021-01390-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34384442"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34384442"}]}]}]}
|
Synonyms | NKEF-B, TDPX1, HEL-S-2A, PRX2, NKEFB, TSA, PRXII, TPX1 |
Proteins | PRDX2_HUMAN |
NCBI Gene ID | 7001 |
API | |
Download Associations | |
Predicted Functions |
![]() |
Co-expressed Genes |
![]() |
Expression in Tissues and Cell Lines |
![]() |
PRDX2 has 13,270 functional associations with biological entities spanning 8 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 119 datasets.
Click the + buttons to view associations for PRDX2 from the datasets below.
If available, associations are ranked by standardized value
Dataset | Summary | |
---|---|---|
Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of PRDX2 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of PRDX2 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of PRDX2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of PRDX2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of PRDX2 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of PRDX2 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PRDX2 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PRDX2 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of PRDX2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of PRDX2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
CCLE Cell Line Proteomics | Cell lines associated with PRDX2 protein from the CCLE Cell Line Proteomics dataset. | |
CellMarker Gene-Cell Type Associations | cell types associated with PRDX2 gene from the CellMarker Gene-Cell Type Associations dataset. | |
ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of PRDX2 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
ChEA Transcription Factor Targets | transcription factors binding the promoter of PRDX2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of PRDX2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PRDX2 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing PRDX2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing PRDX2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with PRDX2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with PRDX2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of PRDX2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
COSMIC Cell Line Gene Mutation Profiles | cell lines with PRDX2 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
CTD Gene-Chemical Interactions | chemicals interacting with PRDX2 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
CTD Gene-Disease Associations | diseases associated with PRDX2 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of PRDX2 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
DepMap CRISPR Gene Dependency | cell lines with fitness changed by PRDX2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with PRDX2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with PRDX2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
DisGeNET Gene-Disease Associations | diseases associated with PRDX2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
DisGeNET Gene-Phenotype Associations | phenotypes associated with PRDX2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
DrugBank Drug Targets | interacting drugs for PRDX2 protein from the curated DrugBank Drug Targets dataset. | |
ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at PRDX2 gene from the ENCODE Histone Modification Site Profiles dataset. | |
ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of PRDX2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
ENCODE Transcription Factor Targets | transcription factors binding the promoter of PRDX2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing PRDX2 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
GAD Gene-Disease Associations | diseases associated with PRDX2 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
GAD High Level Gene-Disease Associations | diseases associated with PRDX2 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of PRDX2 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
GeneRIF Biological Term Annotations | biological terms co-occuring with PRDX2 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing PRDX2 from the GeneSigDB Published Gene Signatures dataset. | |
GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of PRDX2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of PRDX2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of PRDX2 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PRDX2 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of PRDX2 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of PRDX2 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
GO Biological Process Annotations 2015 | biological processes involving PRDX2 gene from the curated GO Biological Process Annotations 2015 dataset. | |
GO Biological Process Annotations 2023 | biological processes involving PRDX2 gene from the curated GO Biological Process Annotations 2023 dataset. | |
GO Biological Process Annotations 2025 | biological processes involving PRDX2 gene from the curated GO Biological Process Annotations2025 dataset. | |
GO Cellular Component Annotations 2015 | cellular components containing PRDX2 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
GO Molecular Function Annotations 2015 | molecular functions performed by PRDX2 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
GO Molecular Function Annotations 2023 | molecular functions performed by PRDX2 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
GO Molecular Function Annotations 2025 | molecular functions performed by PRDX2 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
GTEx Tissue Gene Expression Profiles | tissues with high or low expression of PRDX2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of PRDX2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PRDX2 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of PRDX2 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
HMDB Metabolites of Enzymes | interacting metabolites for PRDX2 protein from the curated HMDB Metabolites of Enzymes dataset. | |
HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of PRDX2 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
HPA Tissue Gene Expression Profiles | tissues with high or low expression of PRDX2 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
HPA Tissue Protein Expression Profiles | tissues with high or low expression of PRDX2 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PRDX2 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
Hub Proteins Protein-Protein Interactions | interacting hub proteins for PRDX2 from the curated Hub Proteins Protein-Protein Interactions dataset. | |
HuBMAP Azimuth Cell Type Annotations | cell types associated with PRDX2 gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
HuGE Navigator Gene-Phenotype Associations | phenotypes associated with PRDX2 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
InterPro Predicted Protein Domain Annotations | protein domains predicted for PRDX2 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of PRDX2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
KEA Substrates of Kinases | kinases that phosphorylate PRDX2 protein from the curated KEA Substrates of Kinases dataset. | |
Kinase Library Tyrosine Kinome Atlas | kinases that phosphorylate PRDX2 protein from the Kinase Library Tyrosine Kinome Atlas dataset. | |
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of PRDX2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of PRDX2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with PRDX2 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of PRDX2 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of PRDX2 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of PRDX2 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PRDX2 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
LOCATE Curated Protein Localization Annotations | cellular components containing PRDX2 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain PRDX2 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by PRDX2 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
MiRTarBase microRNA Targets | microRNAs targeting PRDX2 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of PRDX2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of PRDX2 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by PRDX2 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
MSigDB Cancer Gene Co-expression Modules | co-expressed genes for PRDX2 from the MSigDB Cancer Gene Co-expression Modules dataset. | |
MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of PRDX2 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of PRDX2 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
NURSA Protein Complexes | protein complexs containing PRDX2 protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
Pathway Commons Protein-Protein Interactions | interacting proteins for PRDX2 from the Pathway Commons Protein-Protein Interactions dataset. | |
PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of PRDX2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of PRDX2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
PFOCR Pathway Figure Associations 2023 | pathways involving PRDX2 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
PFOCR Pathway Figure Associations 2024 | pathways involving PRDX2 protein from the Wikipathways PFOCR 2024 dataset. | |
Phosphosite Textmining Biological Term Annotations | biological terms co-occuring with PRDX2 protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset. | |
PhosphoSitePlus Phosphosite-Disease Associations | diseases associated with PRDX2 protein from the curated PhosphoSitePlus Phosphosite-Disease Associations dataset. | |
PhosphoSitePlus Substrates of Kinases | kinases that phosphorylate PRDX2 protein from the curated PhosphoSitePlus Substrates of Kinases dataset. | |
ProteomicsDB Cell Type and Tissue Protein Expression Profiles | cell types and tissues with high or low expression of PRDX2 protein relative to other cell types and tissues from the ProteomicsDB Cell Type and Tissue Protein Expression Profiles dataset. | |
Reactome Pathways 2014 | pathways involving PRDX2 protein from the Reactome Pathways dataset. | |
Reactome Pathways 2024 | pathways involving PRDX2 protein from the Reactome Pathways 2024 dataset. | |
Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of PRDX2 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of PRDX2 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of PRDX2 gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of PRDX2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PRDX2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at PRDX2 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of PRDX2 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of PRDX2 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with PRDX2 protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of PRDX2 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of PRDX2 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of PRDX2 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of PRDX2 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of PRDX2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of PRDX2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of PRDX2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of PRDX2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with PRDX2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with PRDX2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
WikiPathways Pathways 2014 | pathways involving PRDX2 protein from the Wikipathways Pathways 2014 dataset. | |
WikiPathways Pathways 2024 | pathways involving PRDX2 protein from the WikiPathways Pathways 2024 dataset. | |